2025-04-15 - Analysis Report
## Rocket Lab USA Inc (RKLB) Stock Review

**0. Key Figures:**

* **Cumulative Return (RKLB):** 138.18%
* **Cumulative Return (VOO):** 13.71%
* **Return Difference (RKLB vs VOO):** 124.5%
* **Relative Divergence:** 73.9% (Indicates RKLB's performance is in the 73.9th percentile relative to its historical performance against VOO)
* **Current Price:** $19.13
* **Market Risk Indicator (MRI):** 0.4585 (High Risk)


**1. Company Overview & Performance Comparison:**

Rocket Lab USA Inc is a leading provider of launch services and space systems.  RKLB significantly outperformed the S&P 500 (VOO) over the analyzed period, with a cumulative return far exceeding that of the index. While the relative divergence suggests a high performance level compared to its own historical fluctuations against the S&P 500, it's crucial to consider the volatility implied by the high MRI.  The Alpha values are consistently close to zero, suggesting the stock's performance is primarily driven by market movements (Beta values indicate higher than average market sensitivity). However, the Beta increases significantly in recent periods, hinting at growing market sensitivity.

| Year       | CAGR | MDD  | Alpha | Beta | Cap(B) |
|------------|------|------|-------|------|-------|
| 2020-2022  | -39.0% | 70.8% | -36.0% | 0.0 | 1.7 |
| 2021-2023  | 0.0% | 71.5% | -17.0% | 0.0 | 2.5 |
| 2022-2024  | 189.0% | 74.7% | 0.0 | 11.6 |
| 2023-2025  | 157.0% | 74.7% | -0.0 | 8.7 |


**2. Recent Price Movement:**

* **Closing Price:** $19.13
* **Previous Close:** $19.63
* **5-Day Moving Average:** $19.23
* **20-Day Moving Average:** $18.73
* **60-Day Moving Average:** $22.68

The stock price shows a recent decline, currently trading below its 5-day and 60-day moving averages, indicating a bearish short-term trend.  The price is slightly above its 20-day moving average, suggesting some potential support.


**3. Technical Indicators & Expected Return:**

* **RSI:** 45.80 (Slightly below neutral; neither overbought nor oversold)
* **PPO:** 1.75 (Positive, suggesting potential bullish momentum)
* **Delta_Previous_Relative_Divergence:** 5.3 (+), indicating a short-term upward trend in relative strength.
* **Expected Return:** -7.1% (Short-term negative expectation). The -2.55 change in price from the previous close reflects a negative market event.  The long-term (2+ years) expected return relative to the S&P 500 isn't provided, however the high historical outperformance should be considered relative to the higher risk.

**4. Recent Earnings Analysis:**

| Date       | EPS   | Revenue       |
|------------|-------|---------------|
| 2024-11-12 | -0.1  | $0.10 B       |
| 2024-08-08 | -0.08 | $0.11 B       |
| 2024-05-06 | -0.09 | $0.09 B       |
| 2023-11-08 | -0.08 | $0.07 B       |
| 2024-11-12 | -0.08 | $0.07 B       | *(Duplicate entry â€“ likely a typo)*

Revenue shows modest growth but consistent negative EPS demonstrates the company is not yet profitable. Further investigation into the drivers of these losses is needed to fully assess the financial health of the company.


**5. Financial Information:**

**Revenue and Profitability:**

| Quarter     | Revenue     | Profit Margin |
|-------------|-------------|---------------|
| 2024-12-31  | $0.13B      | 27.81%        |
| 2024-09-30  | $0.10B      | 26.71%        |
| 2024-06-30  | $0.11B      | 25.56%        |
| 2024-03-31  | $0.09B      | 26.06%        |
| 2023-12-31  | $0.06B      | 25.82%        |

Revenue is growing, and profit margins remain relatively stable and positive.

**Capital and Profitability:**

| Quarter     | Equity      | ROE           |
|-------------|-------------|---------------|
| 2024-12-31  | $0.38B      | -13.69%       |
| 2024-09-30  | $0.42B      | -12.37%       |
| 2024-06-30  | $0.46B      | -9.15%        |
| 2024-03-31  | $0.48B      | -9.24%        |
| 2023-12-31  | $0.55B      | -9.11%        |

Equity is decreasing, and ROE is negative, indicating the company is not generating returns on its equity.  This is a significant concern and requires further analysis to understand the causes.


**6. Overall Analysis:**

RKLB has shown exceptional historical outperformance compared to the S&P 500, but this comes with significant risk, as indicated by the high market risk indicator and the negative ROE.  While revenue is growing and profit margins are positive, the company is currently unprofitable, and equity is declining. The recent price decline and negative short-term expected return suggest caution.  A long-term investment might be considered only after a thorough understanding of the underlying drivers of profitability and a decrease in risk.  Further analysis into the causes of negative EPS and declining equity is crucial before making any investment decisions.  The high Beta suggests that the stock's price will be highly sensitive to overall market movements.
